Speaker Faculty

  • Alan Crowther – President Global Markets

    Alliance Life Sciences

  • Ana Ramos – Europe Pricing Manager

    Boston Scientific

  • Daniel Watts – Director of System Operations – Contracting Competency Center

    Johnson & Johnson Health Care Systems Inc.

  • Halima Bengabrit – Global Pricing Director

    Sanofi

  • Sue Caleo-Naeyaert – Global Head Pricing, Market Access and Policy Biosimilars

    Merck Biosimilars

  • Youssef Mamour – EMEA Pricing Director

    Getinge

  • Richard Charter – Head of Market Access & Pricing BD Diabetes Care EMEA

    Becton Dickinson

  • Guy Nuyts – Senior Director Global Pricing Inf Dis-Vaccines-Global Public Health

    Janssen, Pharmaceutical Companies of Johnson and Johnson

  • Henderson Azevedo – Global Pricing Oncology

    Bayer

  • Richard Waygood – Senior Manager, International Pricing & Tender Strategy

    Baxter International Inc.

  • Dr. Vivian Mendonca – Regional Director – Oncology Market Access and Pricing – EEMEA

    MSD

  • Simone Leone – Director, Sales & Pricing Effectiveness Europe

    Boston Scientific

  • Finn Ziegler – Director, Global Patient Access

    LEO Pharma

  • Ruven Remo Eul – Associate Director, Life Sciences

    Highpoint Solutions

  • Marc Abels – Partner

    Monitor Deloitte

  • Adam Kundzewicz – Head of Pricing and Contracting

    Boehringer Ingelheim

  • Ian Tidswell – Independent Consultant

    Een Consulting

  • George Boretos – Co-Founder & Director

    Cube RM

  • Paolo Correale – Director, Leader of Tefen Life Sciences Pricing Practice

    Tefen Management Consulting

  • Dr. Michael Herepath – Managing Director

    Optimal Access Life Science Consulting Ltd.

  • Klaas Postema – Senior Director Market Access & Pricing Generics Europe

    Teva

  • Luca Morreale – Senior Consultant Life Sciences

    HighPoint Solutions

  • Dr. Carolin Miltenburger PhD – Payer Strategy Consultant Life Sciences

    Carolin Miltenburger

  • Giovanny Leon – Pricing & Market Access Director Latin America & Canada (LACan)

    Novartis

  • Giuseppe Monita – Senior Manager, Customer Services, Contracts & Tendering EMEA

    BTG

  • Bertrand Tardivel – Head of Global Pricing

    Takeda Pharmaceuticals

  • Chiara Garavaglia – Partner, Global Leader of Tefen Life Sciences Centre of Excellence & Innovation

    Tefen Management Consulting

Pricing for Value

In its 7th year, our EPP Life Sciences Pricing Forum will once again bring together the best industry’s speakers, senior executives and innovators to discuss the latest developments in the pricing and profit optimisation area.

The event will give you the opportunity to learn, interact and network during 3 days of bootcamps, expert presentations, panel sessions, round tables discussions and exhibition area.

Join 100+ industry leaders in Pharma and MedTech in Europe’s main Pricing Forum dedicated to pricing strategy, payers relationships, price policy and innovative pricing tools.

The Forum’s agenda was created together with the industry, and we are very proud to announce that the 2017 event will include:

  • 4 ground-breaking bootcamps
  • 2 innovative workshops
  • 8 round tables discussions
  • 3 Panel Sessions
  • 2 Breakouts sessions: Pharma & MedTech
  • 25+ senior industry speakers sharing best practices and real case studies

Download the 2017 brochure now for the speaker line-up, agenda, bootcamps, pass information and more.

Watch our 2016 event video

 

Download the 2017 brochure now for the speaker line-up, agenda, bootcamps, pass information and more.

See the 2016 post forum report

 

Download the 2017 brochure now for the speaker line-up, agenda, bootcamps, pass information and more.

Download the 2017 brochure now!

 

 Room  P1180176  P1180617  P1180225
 P1180607  P1190219  P1190050  P1180175
 P1180226  P1180159  P1180280  P1180411

 


5 reasons why you should attend the EPP Life Sciences Pricing Forum in 2017

  1. 100+ senior level executives come together for exclusive keynote presentations, innovative bootcamps, 2 breakouts on Pharma and MedTech, workshops, round tables discussions and unrivalled networking to engage in high level business discussions that will shape the future of pricing
  2. The forum agenda was created together with key industry influencers to include the main industry’s challenges and opportunities
  3. 25+ Speakers delivering interactive workshops, round tables, panel discussions and ground-breaking presentations
  4. Pharma & MedTech Breakouts: Discuss, learn and challenge both strategic and tactical topics
  5. Networking: Face-to-face conversations with top industry experts and your pricing peers during the innovative and interactive forum format – you will meet and do business with the leading industry leaders

Register Today –  Super Early Bird Discount ends August 4th!


Who should be attending?

Every year 100+ attendees gather to discuss and reflect on the latest pricing and market access trends, learn about best business practices and meet world’s best experts in pricing and profit optimisation. The EPP Life Sciences Pricing Forum brings together leading practitioners and experts to discuss, reflect, network and share. The forum is tailored for value, know-how and a unique opportunity for key stakeholdes such as CFO/commercial controller/Pricing and market access leads and VPs /Commercial /Sales Ops /Marketing/CIOs/commercial IT

ATTENDING WITH 2+ GROUP :
contact: mariana.flores@pricingplatform.eu or  britt.dejager@pricingplatform.eu or call +32(0)473.71.76.69.

Register Today – Super Early Bird Discount ends August 4th!


This is an event you must attend!

  • 1 BUILD RELATIONSHIPS

    With more than 1000 minutes of network opportunity, you have plenty of time to connect with pricing colleagues from all over Europe.

  • 2 DISCUSS

    We stimulate an atmosphere of discussion and interaction, the best way to learn.

  • 3 LEARN FROM THE BEST

    A carefully selected speaking team of top pricing professionals, all active within your industry. No general talk, but only to-the point and useful presentations.

  • 4 REFLECT & PRACTICE

    Reflect on your key priorities and how to make it really happen !  Translate your key learnings into real change.

THE PROGRAMME

These are some of the topics included in the agenda:

  • Analysis of key Life Sciences pricing challenges and opportunities ahead
  • Market access and pricing models – how the future will evolve
  • The role of pricing in value based healthcare – How can we translate value into price?
  • Growing in Emerging Markets: The out of pocket challenge
  • Differential pricing & stakeholder engagement strategy
  • Biosimilars Overview: From adjusting to different market access policies to a successful market entry
  • Price and reimbursement for drug combinations – A new frontier in Market Access
  • Oncology market access challenges in the emerging markets
  • New types of contracts to obtain a fair reimbursement of your products
  • RWD and data validation – Understand how the authorities are evaluating products and their expectations of data evidence
  • Risk sharing agreements – are they really working? – Analysis of examples in the industry and its financial and outcomes results
  • Evaluation of the value based concepts in practice
  • How CPQ helps price strategies get executed
  • The successful commercialisation of a pricing strategy
  • Internal and external data to create competitive advantage and improve operation within tendering
  • Innovative pricing schemes based on outcomes
  • How advanced analytics can help spot price optimisation opportunities for a large portfolio of products across different markets
  • International Reference Pricing – How to ensure effective pricing strategies to maximise revenue

And more topics…

Download the 2017 brochure now for the full speaker line-up, agenda, bootcamps, pass information and venue.

October 4th 2017

Contact Forum Producer

Mariana Flores

Speaker Faculty

This is the speaker line-up of the 2017 edition of the EPP Life Sciences Pricing forum. If you would be interested to share your expertise or discuss with focus groups about your industry challenges for next year's edition, please send your contact details and session suggestions to mariana.flores@pricingplatform.eu.

Alan Crowther – President Global Markets (USA)

President, Global Markets - Alliance Life Sciences Alliance Life Sciences


Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.

 

ASK A QUESTION

Ana Ramos – Europe Pricing Manager (Portugal)

Europe Pricing Manager Boston Scientific


Ana’s key responsibility at Boston Scientific is to support the development and implementation of processes and solutions that optimize pricing execution, visibility and governance allowing the business to reflect their products and services value while maximizing profit.

Additionally, she is Country Coordinator for BSC Portugal. This responsibility includes leading the organization in the execution of business goals, ensuring alignment across functions and ensuring European programs and initiatives are embedded in the country.

In the past Ana had different roles in organization as Europe Business Finance Manager of the Endoscopy business leading the development and implementation of the European pricing program, Finance and Planning Analyst for Iberia and Financial controller for Portugal.

Prior to joining BSC, she held positions at Guidant and St. Jude Medical. Ana has a post graduate degree in Tax Management, a degree in Audit and Accounting and is a Certified Accountant.

ASK A QUESTION

Daniel Watts – Director of System Operations – Contracting Competency Center (USA)

Director of System Operations - Contracting Competency Center Johnson & Johnson Health Care Systems Inc.


With 15 years of experience in the Health Care and Life Sciences industry, Daniel has experience in both the Pharmaceutical and Medical Device sectors. Daniel’s 12 year tenure in the Contract and Pricing area includes Project, Program, and Portfolio Management with time spent supporting Global Enterprise Programs. Recently Daniel has Revenue Management System implementation experience in the Asia Pacific region. Currently Daniel is involved with process and system evaluation or system implementations in multiple countries in North America and Europe. Daniel has also taken on leadership roles in sector-wide initiatives for the improvement of contracting practices and adoption of technology or data standards. Daniel holds degrees in Computer Science and Business Management and is a certified PMP.

 

 

ASK A QUESTION

STEERING COMMITTEE FOR THE LIFE SCIENCES INDUSTRY

SPEAKERS FACULTY

Julie Spiesser (France)

Associate Vice President Global Strategic Pricing Sanofi


About Julie

Julie Spiesser is a Health Economist specialized in Market Access and Pricing. She has been working for the Pharma industry since 15 years. She started her carreer at Sanofi R&D working in Psychiatry and Cardiovascular area. She joined the Sanofi European team as Senior Market access Manager and took later on the position of European Outcomes Research Director at Pfizer for anti-infective Disease Area. And since 2010 she is heading the Global Strategic Pricing team of Sanofi.

Tsveta Milanova (USA)

VP Corporate Pricing & Market Access Celgene


About Tsveta

Tsveta Milanova works at Celgene EMEA for six years now, most recently as VP Corporate, Pricing and Market Access. She has led numerous workshops with leading industry experts and also developed market access strategies for pre-launch products and new indications.

Photo Daniel Cho

Daniel Cho (Germany)

Director Marketing, Global Pricing & Competitive Portfolio Analytics - Patient Care and Monitoring Solutions Philips Healthcare


About Daniel

Daniel Cho is currently the Director of Global Pricing for Patient Care and Monitoring Systems, a 3B Euro Business Group under Philips Healthcare. He heads a team of Pricing Managers to use Pricing as a tool to maximise the profitability of PCMS by better manage the Creation, Capturing and Maintenance of the values PCMS can deliver to their end customers.

Sara Aswegan (Switzerland)

Senior Vice President Ultragenyx Pharmaceuticals Inc.


About Sara

Sara has recently joined Ultragenyx Pharmacuetical Inc. as Senior Vice-President. Before that she led the Product Strategy Teams for the MPS II Business in the Rare Disease Business Unit, supporting the second largest revenue contributor for Shire with ELAPRASE, as well as plans for commercial success with the development products for Hunter CNS.

Adam Plich (The Netherlands)

VP, Head of Pricing & Market Access Europe TEVA Pharmaceutical Europe


About Adam

Adam has been working with Teva since 2012 as Head of Pricing and Market Access, first based in London now in Amsterdam.  Teva Pharmaceutical is the world’s largest generic medicines producer, leveraging its portfolio of more than 1,000 molecules to produce a wide range of generic products in nearly every therapeutic area. In specialty medicines, Teva has a world-leading position in innovative treatments for disorders of the central nervous system, including pain, as well as a strong portfolio of respiratory products.

Finn Ziegler – Director, Global Patient Access (Denmark)

Director, Global Patient Access LEO Pharma


Finn has recently joined LEO Pharma, after having worked for 6 years as International Contracts and Pricing Manager with Amgen, responsable for pricing and contract strategy and implementation.

His specialties lie in the domain of pricing research & strategies, health economics, public procurement and reimbursement of pharmaceuticals, public policy & affairs, think tanks, parallel trade and reference pricing in the pharmaceutical industry

 

Gustavo Saraiva (UK)

Head of Pricing and Access Intelligence Otsuka Pharmaceuticals Europe


About Gustavo

Gustavo is the head of the Pricing and Access Intelligence at Otsuka Pharmaceuticals Europe, where he is in charge of developing the pricing strategies for the entire product portfolio as well as providing business intelligence insights to the global organisation. His previous years indicate his wealth and expertise in the finance industry before transitioning into Pricing and Market Access. Prior to joining Otsuka he worked with LEO Pharma for three years as a Global Pricing Manager where he had to manage both strategic and operational pricing at a global and local level. Gustavo graduated in Business administration and has a Masters degree in Finance from NOVA School of Business and Economics in Lisbon – Portugal. He also holds an MBA from Universidade Federal Fluminense in Rio de Janeiro – Brazil.

Alan Crowther – President Global Markets (USA)

President, Global Markets - Alliance Life Sciences Alliance Life Sciences


Alan Crowther, CEO for Alliance Life Sciences, is an industry recognized authority on global pricing and revenue management. With 20 years of consulting and technology experience in the Life Sciences industry, Alan’s leadership is focused on continually innovating to solve business challenges.

 

Richard Fergusson (Switzerland)

EMEA Director of Strategic Pricing BD


About Richard

Richard has 15 years of experience in the Medical Technology industry, in various sales, marketing and strategy roles, with the majority of this time closely connected to the topic of Strategic Pricing. Richard is currently the EMEA Director of Strategic Pricing for Becton Dickinson, a global manufacturer of diagnostic and drug delivery devices. During his 4 years at the company he has led a program to build and shape strategic pricing capabilities across the region, as well as taking responsibility for building the regional Health Economics function and for various global pricing programs focused on implementation and adoption of pricing related systems and harmonised processes. Richard started his career as a medicinal chemist, spent a number of years as a management consultant with Andersen prior to completing his MBA at Leeds University Business School, during which time he worked closely with academics and local business incubators to research the topic of technology transfer. He has recently returned to academia to study part time for a Masters in International HTA and healthcare reimbursement at the University of Sheffield.

 

Bertrand Tardivel – Head of Global Pricing (Switzerland)

Head of Global Pricing Takeda Pharmaceuticals


Bertrand is the Head of Global Pricing at Takeda. He joined Takeda when the company started its transformation to a specialty care Pharma company 4 years ago. Bertrand has developed his expertise in a variety of new therapies in Onco-Hemato and GI spanning from chemicals to biologics and, more recently, new therapies based on stem cells.

Bertrand has a broad understanding of the Pharma industry, gained in the various roles he has held in Life Sciences, prior to joining Takeda.  He has extensive experience in Finance, Forecasting and Business Development in both pharmaceutical companies and consulting positions.

Chiara Garavaglia – Partner, Global Leader of Tefen Life Sciences Centre of Excellence & Innovation (Italy )

Partner, Global Leader of Tefen Life Sciences Centre of Excellence & Innovation Tefen Management Consulting


Chiara is a Partner at Tefen Europe and Global Leader of Tefen Life Sciences Centre of Excellence & Innovation. She has been working for more than 20 years in consulting, with key focus on medical devices, pharmaceutical and healthcare areas.

More than ten years ago, Chiara pioneered an innovative Healthcare Partnership approach, developing a large network of Life Sciences and Healthcare companies and supporting them in establishing win-win solutions.

During her professional path, she created leading-edge offerings and expertise in Healthcare Solutions, Multichannel, New Product Launch, Pricing, Commercial Excellence and executed projects at local and global level for more than fifty companies amongst the largest Life Sciences companies in the world.

She also supports med-tech start-ups and operates as advisory for investment funds and venture capitals.

 

WHAT ATTENDEES LIKE ABOUT THIS EVENT

“A conference really dedicated to Pricing”

Clotilde Noble, at Ferring Pharmaceuticals

Excellent conference with very interesting topics and excellent speakers. I attempted this conference two times and I would like to participate to the next one.

‘I enjoyed the opportunity to meet, listen to and network with pricing professionals.’

Raj Kanapathy, at Siemens Healthcare

I enjoyed the opportunity to meet, listen to and network with pricing professionals in the Life Science industry and would definitely recommend the experience to other pricing professionals.

“It’s much more lively and interactive!”

Madalina Preda, European Pricing Supervisor at Corning BV

It is much more lively and focussed on burning issues in the Life Science markets.

Meet pricing decision makers from:

VENUE

Grand Hotel Suisse Majestic – 4*deluxe

This majestic hotel was originally built during the Belle Epoque in 1870 and entirely renovated in 2010. The hotel is just on the lakefront and so you get a phenomenal view of the lake, the promenade, the gardens and of course the snow capped mountains.   Take a look at this splendid hotel !

Please note that we have a limited number of rooms at preferred rates at our disposal : contact Britt Dejager on britt.dejager@pricingplatform.eu to book now !

Avenue des Alpes 45, 1820 Montreux, Zwitserland- +41 21 966 33 33 – hotel website

The easiest way to get to Montreux is to take the train from Geneva Airport direct to Montreux (CHF 35.-/ 2nd class and CHF 62.-/ 1st class)
There is a direct train every 20 minutes (http://www.sbb.ch/en/timetable.html ) – the hotel is straight across the train station.
A taxi will be about CHF 350.-

Photo Grand Hotel Suisse Majestic

Snow capped mountains…

Grand Hotel Suisse Majestic5

…with a great view to the lake…

Grand Hotel Suisse Majestic3

…all comfort in the Belle Epoque…

P1180175

Share, learn and discuss

Grand Hotel Suisse Majestic4

…in an inspiring environment.

P1180607

Perfect work-pleasure combination!

CONTENT

Download HPS White Paper Tender Management

Tender Management by Highpoint Solutions

Tenders are a specific form of centralized procurement:

Either by public health authorities, purchasing organizations or private chains acting as issuing bodies. The majority of countries and healthcare authorities continuously face shrinking budgets and therefore have looked to the cost-saving potential of T&C concepts for their respective countries. All of these issuing bodies have a formal and structured procurement process to obtain several benefits.

In this white paper you will learn:

  • Benefits of Implementing T&C for Healthcare Authorities
  • Benefits of Implementing T&C for Life Sciences

Download Pricing challenges in MedTech

The challenges facing the MedTech market and actions manufacturers can take to address these challenges:

MedTech implications of Healthcare spending.

How Healthcare spending be reallocated?

Where do products and innovations add value?

The impact of innvovation on Healthcare stakeholders.

Find the answers to these questions in the  presentation delivered by Ian Tidswell, Founder and LeadConsultant at een consulting GmbH.

 

Simply fill in your details to download the thought leadership content.

 

EPP PARTNERSHIPS

MEDIA PARTNERS

REGISTRATION

SAVE €400 if you register by 4th august 2017

- If you are a Belgian based company (VAT required), please contact britt.dejager@pricingplatform.eu to complete your registration.
- Click on the 'Show other payment options' to pay by bank transfer.
- EPP Members benefit from our preferred membership rates? Check out the conditions for membership at http://www.pricingplatform.eu/participate/becomeaparticipant/corporate-membership.html
- Once a registration is completed, tickets are transferable but never refundable. This applies to payments via invoice as well.